Position

Co-founder & COO

Information

Dr. Andreas I. Jensen is a radiopharmaceutical chemist with 14 years of experience in the field. He studied pharmacy at the University of Copenhagen and entered the PhD program at the Technical University of Denmark (DTU) with a focus on radiochemistry and biomedical nanotechnology. Obtaining his PhD degree in 2012 he continued as research scientist at DTU and in 2017 was promoted to senior research scientist. In 2020, he received a Sapere Aude starting grant from the Danish Council for Independent Research and started an independent research group with a focus on drug delivery strategies for radionuclide therapy and theranostics. Apart from academic research, he has developed radiolabeling procedures and formulations for radiopharmaceuticals intended for clinical use, including GMP production and industry collaborations. His current profile combines applied academic research with commercial and pre-commercial innovation.